Constant, John C.I.

Dianhydrogalactitol in bevacizumab-refractory GBM: Further analysis of a phase 1-2 trial.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2061-2061

10.1200/jco.2018.36.15_suppl.2061